Back to search

Article

Global screening and genetic engineering of Tistrella enable sustainable production of didemnin drugs

2023-05-04

Abstract excerpt

<title>Abstract</title> <p>The <italic>Tistrella</italic> genus can produce the cyclic depsipeptide didemnin B, but the biosynthetic origin of its analogue, plitidepsin, remains unknown. Plitidepsin is an approved anticancer drug and an anti-COVID-19 agent in phase III clinical trials. Here, we employed a novel approach that combined microbial and chemical synthesis to produce plitidepsin. We first investigated t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8f3b931c-9867-5792-817e-9d77b086f19e
DOI
10.21203/rs.3.rs-2879035/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Global screening and genetic engineering of Tistrella enable sustainable production of didemnin drugsDOI 10.21203/rs.3.rs-2879035/v1
Select a neighboring publication to make it the new centre.